PDLIM7 and Burkitt lymphoma: The authors next examined the efficacy of αDEC-E1 plus Adeno–E1-LMP or Adeno–E1-LMP plus MVA-IiE1 in mice challenged with tumor cells designed to mimic Burkitt lymphoma cells expressing c-Myc.